NurseJet
Back to Discover
Research ArticleResearchMedication Safety

Stepping down blood pressure drugs in frail nursing home residents did not change survival in an RCT

New England Journal of Medicine (PubMed)Nov 1, 2025

AI-summarized from the linked source. Educational brief, not medical advice.

Brief summary

A randomized controlled trial found that a protocol-driven step-down of antihypertensive drugs in frail nursing home residents did not change all-cause mortality compared with usual care.

What NurseJet pulled from the source

In 1,048 nursing home residents aged 80 or older taking more than one antihypertensive with systolic pressure below 130 mm Hg, a step-down strategy roughly halved the average number of antihypertensives while raising systolic pressure about 4 mm Hg. All-cause death was similar between groups (61.7% vs 60.2%; adjusted hazard ratio 1.02), with no apparent difference in adverse events.

Why this matters for nurses

Polypharmacy and over-treatment are everyday concerns in long-term care, where blood pressure targets for frail elders are debated. This may matter for nurses because it provides high-quality evidence that, in this population, carefully reducing antihypertensives was safe and lowered pill burden without improving or worsening survival.

Bedside takeaway

Worth knowing that in frail nursing home residents 80 and older, a protocol-driven step-down of antihypertensives roughly halved pill burden without changing survival, with no apparent difference in adverse events.

Key takeaways

  • In 1,048 frail residents, an antihypertensive step-down did not change all-cause mortality versus usual care (HR 1.02).
  • Step-down roughly halved the average number of antihypertensives while raising systolic pressure about 4 mm Hg.
  • Adverse events did not appear to differ between groups.
  • The result supports the safety of careful deprescribing, not a blanket instruction to stop medications.

Practice implications

  • Support structured, monitored deprescribing in frail elders rather than abrupt stops and only within a provider-led plan, continue routine blood pressure monitoring and watch for symptoms when medications are reduced, and use the findings to inform shared decision-making about pill burden.

Limitations & cautions

  • Results apply specifically to frail residents 80 and older with systolic pressure below 130 mm Hg, not to all patients. Medication changes are prescriber decisions; nurses support monitoring and do not adjust regimens independently.
  • AI-summarized from the linked source. Review the original article before applying to practice.

Citations

Exact source links

Public citations are filtered to exact credible source pages. Homepage-only or invalid links stay in admin review and are not shown here.

New England Journal of Medicine (PubMed)

New England Journal of Medicine (PubMed). Reduction of Antihypertensive Treatment in Nursing Home Residents.

Open original source

https://pubmed.ncbi.nlm.nih.gov/40879421/

Professional education only

This summary does not replace clinical judgment, facility policy, provider orders, or official guidelines. Verify practice changes against the original source and local protocol.

Related briefs

More updates for this clinical area

Back to Discover

Journal of the American Medical Directors Association (PubMed)

A prospective Dutch nursing-home cohort found clinically important differences in illness burden across respiratory viruses, with influenza and human metapneumovirus standing out.

GeriatricsMed-SurgAI summaryReview source

BMC geriatrics (PubMed)

A multicountry emergency-department analysis found that older patients' presenting complaints did not by themselves reflect underlying severity or disposition risk.

EmergencyGeriatricsAI summaryReview source

Lancet (London, England) (PubMed)

A pragmatic randomized trial found no clinically meaningful 12-month patient benefit from robotic-arm-assisted versus conventional total knee replacement.

Med-SurgGeriatricsAI summaryReview source